Ernest Samuel Nossen and E. S. Nossen Laboratories, Inc. v. The United States

422 F.2d 1340, 191 Ct. Cl. 198, 165 U.S.P.Q. (BNA) 82, 1970 U.S. Ct. Cl. LEXIS 25
CourtUnited States Court of Claims
DecidedMarch 20, 1970
Docket350-61
StatusPublished
Cited by4 cases

This text of 422 F.2d 1340 (Ernest Samuel Nossen and E. S. Nossen Laboratories, Inc. v. The United States) is published on Counsel Stack Legal Research, covering United States Court of Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ernest Samuel Nossen and E. S. Nossen Laboratories, Inc. v. The United States, 422 F.2d 1340, 191 Ct. Cl. 198, 165 U.S.P.Q. (BNA) 82, 1970 U.S. Ct. Cl. LEXIS 25 (cc 1970).

Opinion

ON PLAINTIFFS’ MOTION FOR REHEARING

PER CURIAM.

Following the decision of this court, 416 F.2d 1362, 189 Ct.Cl. 1, (1969), that the patent claims were invalid and that the suit under Title 28 U.S.C. § 1498 (1964) must be dismissed, the plaintiffs have made a timely motion for rehearing under Rule 151. The motion must be and is denied for the reasons that follow:

Our conclusion that the claims were invalid rested entirely upon anticipating disclosures by a German scientist, a Dr. Geweeke, in a patent which the German patent office issued to him in 1932, No. 556,882, and in two articles Dr. Geweeke published in the German technical press in 1934 and 1936. Defendant relied on other prior art but we did not pass upon it because the Geweeke disclosures were considered decisive. Plaintiffs now say in their motion that we misconstrued Dr. Gewecke’s writings, though before us in admittedly accurate translations, and that his disclosures were different from what we thought. To determine whether plaintiffs set forth adequate grounds under Rule 151 it is necessary to go back to the original trial of the case and trace events from that point.

Defendant offered the Geweeke patent and articles in evidence in course of presenting its ease after plaintiffs had rested. Defendant’s expert witnesses testified what they thought Gewecke’s meanings were and the nature of the processes he disclosed. The individual plaintiff Dr. Nossen, had testified in chief, but was not asked about the Geweeke disclosures and gave no testimony on that subject. Plaintiffs’ rebuttal testimony was brief and did not allude to Geweeke. Dr. Nossen did not take the stand again.

In this connection, the record shows that Dr. Nossen was a native German and that he was awarded a Ph.D., degree in chemistry in Breslau in 1929. He also studied in Berlin and Charlottenberg. He-applied for a German patent as early as 1932. He was employed up to 1936 by a German company, being stationed in Berlin and Copenhagen, apparently under the same employer in both places. In 1936 he entered employment in the Netherlands and in the early 1940’s Hitler deprived him of German citizenship. He was apparently in exile during World War II, and first came to the United States in 1948. He organized the plaintiff corporation in 1950. It follows that Dr. Nossen was a fellow chemist in Germany with Dr. Geweeke at the time when Geweeke was awarded his patent and at the time of the first Geweeke article.

Commissioner, now Judge, Donald E. Lane, after hearing the testimony, filed *1342 a recommended opinion and findings with the court which, respecting Gewecke, substantially foreshadowed the conclusion the court ultimately came to. The briefing and oral argument that followed before us revealed that the parties were far apart as to what Gewecke had disclosed.

By order of January 24, 1968, the court remanded the case to Commissioner Lane for further findings on the validity of the patent in suit, and on the issue of infringement insofar as that question may depend upon the further discussion and finding on validity. The order continues as follows:

* * * The further opinion and findings should elucidate the similarities and differences between the patent in suit and the Gewecke publications, including (but not limited to) the bearing of these similarities and differences on the plaintiffs’ contentions that (a) the patent in suit does, and the Gewecke publications do not, teach the “subjection” (rather than the mere heating) of the metal nitrates to a temperature higher than their decomposition temperature, and that this difference in treatment makes a patentable difference in result, and (b) that the plaintiffs’ process is applicable to a large number of metals while that of the Gewecke publications is applicable only to a few. The commissioner has leave, in his discretion and if he deems it necessary or desirable to allow the parties to present further evidence and/or further argument, written or oral.

Commissioner Lane’s subsequent supplemental opinion and findings revealed that plaintiffs moved on May 13, 1968, that no further trial sessions be had and that no further evidence be adduced. The result was that Commissioner Lane made his supplemental report without the benefit of additional evidence.

The record reflects that Dr. Nossen himself would well qualify as an expert and that he could not but possess a knowledge of the state the art of chemistry had reached in Germany in 1932, that could be matched by few other persons indeed who might be brought before this court today.

Our asserted misconstruction of the Gewecke process or processes (we do not exclude the possibility there might have been more than one) is that we stated at page 6 (slip op., 416 F.2d at 1366), that the “agitated bed” of Gewecke was: “continuously maintained at a temperature at or above the temperature of thermal decomposition of aluminum nitrate, say 180° C„” (reference is made to the description of Gewecke’s processes in the original opinion, which need not be repeated here, to explain the relevance of this). Plaintiffs’ counsel says that after publication of our decision he submitted to 22 scientists of his acquaintance the full text of the Gewecke patent together with his own explanation of it and ours, without indicating which one favored his litigation position. He heard from 17, who all agreed that his interpretation was correct. Copies of their letters are attached as exhibits to the motion.

The interpretation thus unanimously endorsed was that Gewecke’s “agitated bed” was really a moving conveyor, such as a screw conveyor, which moved cold particles past a spraying station where hot aluminum nitrate solution was sprayed upon them, after which the particles went to a decomposer where the decomposition of the aluminum nitrate was consummated by heat.

This is the first time any conveyor, screw or otherwise, has been heard from in this proceeding. Without the aid of expert testimony it would be impossible for this court to determine whether the explanation is more credible than the one put forth by defendant’s experts and adopted by us. Some of the responses show that it is difficult for anyone to interpret a German patent of 1932 vintage without actual knowledge of the state of the art in Germany at that time. Apparently, according to them, the Gewecke patent is an example of a style of presentation in which a great deal is left unsaid, relying on the read *1343 er’s extrinsic knowledge. That is, supposedly, why he omitted to mention the conveyor. We note, however, that only one of the 17 respondents was actually a practicing chemist in Germany at the German patent date, 1932. In this respect Dr. Nossen himself appears to possess a marked advantage over counsel’s pollees.

It seemed apparent to us when we entered the order, supra, that further inquiry as to what Gewecke meant would require further testimony by plaintiffs which, of course, defendant would have to be given an opportunity to rebut. This is what the court expected to happen and invited when making its order of remand to the commissioner, supra.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fred A. Arnold, Inc. v. United States
37 Cont. Cas. Fed. 76,146 (Court of Claims, 1991)
Pennco Trucking Inc. v. United States
20 Cl. Ct. 534 (Court of Claims, 1990)
Douglas v. United States
510 F.2d 364 (Court of Claims, 1975)
Nicholas C. Ricucci v. The United States
432 F.2d 453 (Court of Claims, 1970)

Cite This Page — Counsel Stack

Bluebook (online)
422 F.2d 1340, 191 Ct. Cl. 198, 165 U.S.P.Q. (BNA) 82, 1970 U.S. Ct. Cl. LEXIS 25, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ernest-samuel-nossen-and-e-s-nossen-laboratories-inc-v-the-united-cc-1970.